• Modern diagnosis and treatment of preterm premature rupture of membranes (a literary review)

Modern diagnosis and treatment of preterm premature rupture of membranes (a literary review)

PERINATOLOGIYA I PEDIATRIYA. 2017.2(70):48-52; doi 10.15574/PP.2017.70.48

Demenina N. K., Ishchenko A. I.
SI «Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine», Kyiv

Rupture of membranes is one of the most common and most controversial issues in obstetrics. Amniotic fluid, which is essential to biomechanics of child-birth, has a great physiological importance for the delivery and fetus, because the fluid creates the conditions for free development and movement, as well as protect the growing organism from adverse factors. Spontaneous rupture of membranes is a normal component of delivery. Preterm premature rupture of membranes refers to the membranes rupture before labor begins, regardless of gestational age. When the rupture of membranes occurs, it is recommended to activate the labor when the risk of ascending infection outweighs the risk of prematurity. When preterm premature rupture of membranes is observed, the labor usually occurs spontaneously or is activated within 12 to 24 hours themselves. Management of pregnancy, which is complicated with preterm premature rupture of membranes (applies to premature rupture of membranes up to 37 weeks gestation), is more complex. Preterm premature rupture of membranes complicates from 2% to 20% of all labors and is associated with 18% to 20% of perinatal mortality. Capabilities of labor management include admission to hospital, amniocentesis to make impossible intrauterine infection and the prenatal administration of corticosteroids and broad-spectrum antibiotics, if necessary. Despite the fact that infection is considered to be the leading factor of preterm premature rupture of membranes, etiology and pathogenesis of the latter remains underinvestigated.

Key words: preterm premature rupture of membranes, preterm labor, antibiotics, corticosteroids.

Referens
1. Abramchenko VV. (2003). Farmakoterapiya prezhdevremennyih rodov. 1 t. Moskva, MedEkspertPress; Petrozavodsk, Izd-vo Intel-Tek: 448.

2. Analiz smertnosti ta naslidkiv peredchasnykh polohiv: vid novonarodzhenoi dytyny do dorosloi liudyny. Chastyna 2 serii «Peredchasni polohy». (2011). Z turbotoiu pro zhinku. 3(24): 26—31.

3. Veropotvelyan PN, Veropotvelyan NP, Panasenko AN. (2012). Prezhdevremennoe izlitie okoloplodnyih vod pri nedonoshennoy beremennosti — chto delat? Zdorove zhenschinyi. 1(67): 99.

4. Gluhovets BI. (2006). Voshodyaschee infitsirovanie fetoplatsentarnoy sistemyi. Moskva, MEDpress-inform: 240.

5. Dvoryanskiy SA, Araslanova SN. (2002). Prezhdevremennyie rodyi. Moskva, Medichna kniga; Nizhniy Novgorod, Izd-vo NGMA: 93.

6. Kulakov VI, Murashko LE. (2002). Prezhdevremennyie rodyi. Moskva, Meditsina: 176.

7. Ordzhonikidze NV, Fedorova TA, Danelyan SZh. (2004). Endometrit i ranevaya infektsiya u rodilnits. Problemyi i puti ih resheniya. Akusherstvo i ginekologiya. 5: 3—5.

8. Gromova AM, Taranovska OO, Talash VV. (2011). Patomorfologicheskie osobennosti platsentyi i plodnyih obolochek u beremennyih s prezhdevremennyim izlitiem okoloplodnyih vod. Visnyk problem biolohii i medytsyny. 2; 1: 182—184.

9. Radzinskiy VE, Milovanov AP. (2004). Ekstraembrionalnyie i okoloplodnyie strukturyi pri normalnoy i oslozhnennoy beremennosti. M, Meditsinskoe informatsionnoe agentstvo: 393.

10. Sidelnikova VM. (2000). Privyichnaya poterya beremennosti. Moskva, Triada-H: 304.

11. Pasquier JC, Rabilloud M, Picaud JC et al. (2005). A prospective population-based study of 598 cases of PPROM between 24 and 34 weeks'gestation: description, management and mortality (DOMINOS cohort). DOMINOS Group. Eur J Obstet Gynecol Reprod Biol. 121: 164—170. https://doi.org/10.1016/j.ejogrb.2004.12.015; PMid:16054957

12. ACOG Committee on Practice Bulletins-Obstetrics, authors. Clinical management guidelines for obstetrician-gynecologists. (ACOG Practice Bulletin No. 80: premature rupture of membranes) (2007). Obstet Gynecol. 109: 1007—1019. https://doi.org/10.1097/01.AOG.0000263888.69178.1f; PMid:17400872

13. Cousins LM, Smok DP, Lovett SM, Poeltler DM. (2005). Amnisure placental alpha macroglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol. 22: 317—320. https://doi.org/10.1055/s-2005-870896; PMid:16118720

14. Caughey AB, Robinson JN, Norwitz ER. (2008). Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 1: 11—22. PMid:18701929 PMCid:PMC2492588

15. Ramsey PS, Lieman JM, Brumfield CG, Carlo W. (2005). Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 192: 1162—1166. https://doi.org/10.1016/j.ajog.2004.11.035; PMid:15846196

16. Bornstein J, Ohel G, Sorokin Y et al. (2009). Effectiveness of a novel home-based testing device for the detection of rupture of membranes. Am J Perinatol. 26(1): 45—50. https://doi.org/10.1055/s-0028-1095183; PMid:18979414

17. Hosseini MA, Nahidi F, Majdfar Z. (2007). Comparison of fern and evaporation tests for detection of ruptured fetal membranes. East Mediterr Health J. 13(1): 197—200. PMid:17546923

18. Kafali H, Oksuzler C. (2007). Vaginal fluid urea and creatinine in diagnosis of premature rupture of membranes. Arch Gynecol Obstet. 275: 157—160. https://doi.org/10.1007/s00404-006-0240-1; PMid:16967274

19. Kenyon S, Boulvain M, Neilson J. (2003). Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev: CD001058. https://doi.org/10.1002/14651858.CD001058

20. Mercer BM. (2004). Preterm rupture of the membranes: diagnosis and management. Clin Perinatol. 31: 765—782. https://doi.org/10.1016/j.clp.2004.06.004; PMid:15519427

21. Bornstein J, Geva A, Solt I et al. (2006). Nonintrusive diagnosis of premature ruptured amniotic membranes using a novel polymer. Am J Perinatol. 23: 351—354. https://doi.org/10.1055/s-2006-947159; PMid:16841279

22. Park JS, Lee SE, Norwitz ER et al. (2007). Noninvasive testing for rupture of the fetal membranes. Touch Briefings: US Obstetrics and Gynecology. 1: 13—16.

23. Mulhair L, Carter J, Poston L et al. (2009). Prospective cohort study investigating the reliability of the AmnioSens method for detection of spontaneous rupture of membranes. BJOG. 116: 313-318. https://doi.org/10.1111/j.1471-0528.2008.01828.x; PMid:18652589

24. Shahin M, Raslan H. (2006). Comparative study of three amniotic fluid markers in premature rupture of membranes: prolactin, beta subunit of human chorionic gonadotropin, and alpha-fetoprotein. Gynecol Obstet Invest. 63: 195—199. https://doi.org/10.1159/000097844; PMid:17159350

25. Vondadelszen P, Kives S, Delisle MF et al. (2003). The Association between early rupture, latency, clinical chorioamnionitis, neonatal infection, and adverse perinatal outcomes pregnancies complicated by preterm prelabour rupture of membranes. Twin Res. 4: 257—262. https://doi.org/10.1375/136905203322296575; PMid:14511428

Содержание журнала Full text of article